Papers: 17 Apr 2015 - 24 Apr 2015
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Is the use of the trivalent influenza vaccine against A (H1N1) pdm09 associated with an increased risk of post-vaccination acute disseminated encephalomyelitis?
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Erratum to: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex(®)) for Spasticity in Multiple Sclerosis.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
Remyelination by Resident Oligodendrocyte Precursor Cells in a Xenopus laevis Inducible Model of Demyelination.
Association between perceived fatigue and gait parameters measured by an instrumented treadmill in people with multiple sclerosis: a cross-sectional study.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Relapsing remitting multiple sclerosis in x-linked charcot-marie-tooth disease with central nervous system involvement.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
ARP2/3 complex is required for directional migration of neural stem cell-derived oligodendrocyte precursors in electric fields.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.